Matthias Schnell

Title	Physician
Institution	Thomas Jefferson University
Department	Chairman - JMC - Thomas Jefferson University
Address	951 Locust Street Philadelphia PA 19107
Phone	215-503-4634
vCard	Download vCard

Research

research activities and funding

R21AI044340 (SCHNELL, MATTHIAS JOHANNES)Sep 30, 1998 - Sep 29, 2000 NIH RABIES VIRUS BASED VECTORS AS AN HIV1 VACCINE Role: Principal Investigator

R21AI049153 (SCHNELL, MATTHIAS JOHANNES)Mar 15, 2001 - May 31, 2005 NIH Rabies Virus-Based Vectors as an HIV -1 Vaccine Role: Principal Investigator

R01AI049153 (SCHNELL, MATTHIAS JOHANNES)Mar 15, 2001 - Feb 28, 2010 NIH Rabies Virus-Based Vectors as an HIV-1 Vaccine Role: Principal Investigator

R21AI051170 (SCHNELL, MATTHIAS JOHANNES)Jul 1, 2002 - Jun 30, 2005 NIH Prime/Boost Immunization against HIV-1 by Viral Vectors Role: Principal Investigator

R21AI062807 (SCHNELL, MATTHIAS JOHANNES)Jul 5, 2005 - Jun 30, 2008 NIH Killed Rhabdoviruses as Novel Anthrax Vaccines Role: Principal Investigator

R01MH074375 (SCHNELL, MATTHIAS JOHANNES)Sep 15, 2005 - Aug 31, 2009 NIH Astrocytes and Restricted HIV-1 Replication Role: Principal Investigator

R41AI063822 (SCHNELL, MATTHIAS JOHANNES)Apr 15, 2006 - Mar 31, 2009 NIH A novel rhabdovirus-based anthrax vaccine Role: Principal Investigator

R41AI073064 (SCHNELL, MATTHIAS JOHANNES)Apr 1, 2008 - Sep 30, 2010 NIH A novel vaccine: botulinum neurotoxin subunit on a viral carrier. Role: Principal Investigator

R21AI081388 (SCHNELL, MATTHIAS JOHANNES)Jun 1, 2009 - May 31, 2012 NIH Bat rabies virus in its natural host Role: Principal Investigator

P01AI082325 (SCHNELL, MATTHIAS JOHANNES)Sep 1, 2009 - Aug 31, 2012 NIH Functional Analysis of NSV-based HIV vectors Role: Principal Investigator

R21NS074006 (SCHNELL, MATTHIAS JOHANNES)Jul 1, 2011 - Jun 30, 2015 NIH Fate of neurons following immune-mediated viral clearance Role: Principal Investigator

R42AI073064 (SCHNELL, MATTHIAS JOHANNES)Jun 21, 2012 - May 31, 2016 NIH A novel vaccine: botulinum neurotoxin subunit on a viral carrier. Role: Principal Investigator

R01AI105204 (SCHNELL, MATTHIAS JOHANNES)Feb 1, 2013 - Jan 31, 2020 NIH Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine Role: Principal Investigator

R01AI127823 (SCHNELL, MATTHIAS JOHANNES)Nov 15, 2016 - Oct 31, 2020 NIH Drug discovery against lyssaviruses by high thoughput screening Role: Principal Investigator

R01AI123272 (SCHNELL, MATTHIAS JOHANNES)Nov 22, 2016 - Oct 31, 2021 NIH Development of a single-dose rabies virus vaccine Role: Principal Investigator

R21AI128175 (SCHNELL, MATTHIAS JOHANNES)Dec 1, 2016 - Nov 30, 2019 NIH Toward an Pan-lyssavirus vaccine Role: Principal Investigator

R21AI135361 (SCHNELL, MATTHIAS JOHANNES)May 16, 2018 - Apr 30, 2021 NIH Development of Rabies-based Virus-like Particles Role: Principal Investigator

T32AI134646 (SCHNELL, MATTHIAS JOHANNES;SIGAL, LUIS J)Sep 1, 2018 - Aug 31, 2023 NIH Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer Role: Co-Principal Investigator

R01AI149795 (SCHNELL, MATTHIAS JOHANNES)Jan 1, 2020 - Dec 31, 2025 NIH Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses Role: Principal Investigator

R21AI158044 (SCHNELL, MATTHIAS JOHANNES)Jul 16, 2020 - Jun 30, 2022 NIH Toward a protective Covid-19 vaccine utilizing an established vector platform Role: Principal Investigator

R01AI154542 (PAL, UTPAL)Jul 20, 2020 - Jun 30, 2026 NIH Multivalent Tick-Microbe targeted Lyme disease vaccines Role: Co-Principal Investigator

R01AI167295 (SCHNELL, MATTHIAS JOHANNES)Aug 25, 2022 - Jul 31, 2026 NIH Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models Role: Principal Investigator

R21AI194176 (SCHNELL, MATTHIAS JOHANNES)Jun 17, 2026 - May 31, 2028 NIH Avian influenza virus prevention in the domestic host by a deactivated vaccine Role: Principal Investigator

R21AI196529 (SCHNELL, MATTHIAS JOHANNES)Sep 1, 2026 - Aug 31, 2028 NIH Novel Dual-Action Anti-tick Vaccine Role: Principal Investigator

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Parveen Z, Mukhtar M, Rafi M, Wenger DA, Siddiqui KM, Siler CA, Dietzschold B, Pomerantz RJ, Schnell MJ, Dornburg R. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology. 2003 Sep 15; 314(1):74-83. PMID: 14517061.

Citations:

Year	Publications
2003	1

Schnell's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (18)

Explore

Co-Authors (3)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement